# Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/phase-iii-study-of-gefitinib-or-pemetrexed-with-carboplatin-in-egfr-mutated/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Vijay Patil,Vanita Noronha,Amit Joshi,Anuradha Choughule,Atanu Bhattacharjee,Rajiv Kumar,Supriya Goud,Sucheta More,Anant Ramaswamy,Ashay Karpe,Nikhil Pande,Arun Chandrasekharan,Alok Goel,Vikas Talreja,Abhishek Mahajan,Amit Janu,Nilendu Purandare,Kumar Prabhash |
| Citations | 71 |
| DOI | 10.1136/esmoopen-2017-000168 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://esmoopen.bmj.com/content/esmoopen/2/1/e000168.full.pdf |
| OpenAlex ID | https://openalex.org/W2608495247 |
| PMID | 28761735 |
| Type | article |
| Year | 2017 |

## Paper authors

- [Atanu Bhattacharjee](https://scholariq.org/researchers/atanu-bhattacharjee/)

## Paper journal

- [ESMO Open](https://scholariq.org/journals/esmo-open/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.